(Date:11/19/2009)... YORK, Nov. 19 NeoStem, ...as sent the following letter to its shareholders, ...0, 2009, of China Biopharmaceuticals Holdings, Inc... based in the People,s Republic of China. The merg...hou Eyre Pharmaceutical Co. Ltd., CHBP,s primary o...
(Date:11/19/2009)... MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewsw...sion Resources find that the leading driver of ant...e is broad-spectrum activity against gram-positive...f organisms that can cause nosocomial pneumonia, s...primarily for agents that provide appropriate cove...
(Date:11/19/2009)...TREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics ...nt in a randomized Phase 2B study of AEG35156, a t...ment for multiple oncology indications. ,, The ...Study of the X-Linked Inhibitor of Apoptosis (XIAP...h-dose Cytarabine and Idarubicin in AML Following ...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies F... to Coordinate Best Practices in Risk Reduction ,...ldwide Gene Synthesis Capacity , ...orld’s leading gene synthesis companies toda...n screening protocol to promote biosecurity in the...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4...5 BSP Ltd.,( http://www.bsp.co.il/pressall.asp ),...tems for non-invasive diagnosis and monitoring of ...perQ(TM) Stress System in the US during,the 57th A...TM) is cutting-edge technology implemented in an i...able, low-cost and risk free,cardiac monitoring fo...
...rosoft technology over competitors for its ease of...abilities., REDMOND, Wash., March 25 Microsoft C...cted Microsoft Dynamics AX 4.0,to speed and integr...,company,s compliance with the Sarbanes-Oxley Act ...uthorities, including the Food and Drug,Administra...
...25 /Xinhua-PRNewswire-FirstCall/ -- China,Biologic... or "the,Company"), one of the leading plasma-base...c of China ("PRC"), today announced that one of it...s B Immunoglobulin", was listed,in the National To...rganized and executed by The Ministry of,Science a...
Other Biology Technology:World Debut for BSP's HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008 2Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 2Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 3Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 4Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 5China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan 2China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan 3... the 9, 10, 12, and 13 positions. It is intended f...ion of 13(S)-HODE by GC- or LC-mass spectrometry. ...cid with plant and mammalian lipoxygenases. It has... to the endothelium at concentrations around 1 ...
pcDNA4/His A B & C from Invitrogen
Adaptor Hind III - Sma I from Takara Mirus Bio
Adaptor Sal I - Sma I from Takara Mirus Bio
Biology Products: